A new perspective: deciphering the aberrance and clinical implication of disulfidptosis signatures in clear cell renal cell carcinoma

Bohong Chen; Mingguo Zhou; Li Guo; Xinyue Sun; Haoxiang Huang; Kaijie Wu; Wei Chen; Dapeng Wu

doi:doi:10.18632/aging.205916

← Back

Research Paper Volume 16, Issue 11 pp 10033—10062

A new perspective: deciphering the aberrance and clinical implication of disulfidptosis signatures in clear cell renal cell carcinoma

Figure 9. Diagnostic value analysis of the DRS in ccRCC. (A) Pie charts showing the chi-square test of clinicopathological factors for DRS in ccRCC. (B–F) AUC analysis of the DRS and other PCD-related models for distinguishing ccRCC from normal RCC. p < 0.05 was considered statistically significant.